HIGHLIGHTS
- who: Malihe-sadat Hashemi-Khah and collaborators from the Department of Microbiology, Damghan Branch, Islamic Azad University, Damghan, Iran have published the paper: An In Vivo Study of Lactobacillus rhamnosus (PTCC 1637) as a New Therapeutic Candidate in Esophageal Cancer, in the Journal: BioMed Research International of 23/06/2022
- what: In this study the cytotoxicity effects of L rhamnosus supernatant and whole-cell culture on a cancer cell line (Kyse30) compared to 5fu were evaluated by the MTT assay. This study was designed to investigate the effect of probiotic Lactobacillus rhamnosus (L. rhamnosus) on . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.